Previous close | 12,166.00 |
Open | 12,186.00 |
Bid | 11,600.00 x 0 |
Ask | 12,470.00 x 0 |
Day's range | 12,068.00 - 12,256.00 |
52-week range | 9,461.00 - 12,488.00 |
Volume | |
Avg. volume | 2,776,855 |
Market cap | 187.734B |
Beta (5Y monthly) | 0.16 |
PE ratio (TTM) | 37.96 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (1.87%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
The following are the top stories on the business pages of British newspapers. - Anglo American rejected a raised takeover offer of 34 billion pounds ($42.67 billion) from BHP Group on Monday, saying the world's largest listed miner "continues to significantly undervalue" the company. - JPMorgan Chase has pledged a further 40 million pounds ($50.22 million) in philanthropic investments in the UK over five years in a sign of its increasing focus on Britain.
Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.